Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Carlota

Carlota Aguilar-Long, Bayou Vista, TX US

Patent application numberDescriptionPublished
20080199841Method to overcome pain and addiction - The present invention is directed to a method of treating pain and addiction in an individual. The mode of treatment is via a class, which combines 1) an alternative to reality through the simulation of real life experience, 2)discussion where individual participants a) identify factors that influenced the characters' and their choices by utilizing a behavior and self diagram, b)Evaluate the opinion of scholars and experts in the field, 3) The use of neuro-linguistic programming excercises to process emotions that have hindered the individual's life. This method provides an individual with alternative choices in life and helps develop positive goals for the future.08-21-2008

Carlota Vinals Bassols, Liege BE

Patent application numberDescriptionPublished
20100204458Process for the Production of Immunogenic Compositions - The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3.08-12-2010
20100209444MAGE3 Polypeptides - The present invention relates to novel MAGE3 polypeptides, including a fragment of MAGE3 fused to an immunological fusion partner, and compositions thereof.08-19-2010

Carlota Vinals Y De Bassols, Rixensart BE

Patent application numberDescriptionPublished
20080249013Vaccines - Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.10-09-2008
20090202577CASB618 Polynucleotides and Polypeptides and Their Use - CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.08-13-2009
20100291121Tumour-Specific Animal Proteins - CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions.11-18-2010
20110052615TUMOUR-SPECIFIC ANIMAL PROTEINS - CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.03-03-2011

Patent applications by Carlota Vinals Y De Bassols, Rixensart BE

Carlota Vinals Y De Bassols, Brussels BE

Patent application numberDescriptionPublished
20100143412BASB027 PROTEINS AND GENES FROM MORAXELLA CATARRHALIS, ANTIGENS, ANTIBODIES, AND USES - The invention provides BASB027 polypeptides and polynucleotides encoding BASB027 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.06-10-2010